Selectivein vitroexpansion and efficient retroviral transduction of human CD34+CD38-haematopoietic stem cells
Open Access
- 25 March 2002
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 117 (1), 226-237
- https://doi.org/10.1046/j.1365-2141.2002.03370.x
Abstract
Summary. Ex vivo expansion of primitive human haematopoietic stem cells (HSC) is clinically relevant for stem cell transplantation and gene therapy. Here, we demonstrate the selective expansion of CD34+CD38– cells from purified CD34+ cells upon stimulation with Flt3‐ligand, stem cell factor and thrombopoietin. Over a 100‐fold (range 80 to 128‐fold) expansion of CD34+CD38– cells was observed with bone marrow and cord blood (CB). The expanded CD34+CD38– cells remained negative for lineage‐specific markers and could be induced to differentiate into granulocytes, monocytes, megakaryocytes, erythrocytes, and T and B‐lymphocytes in vitro. Lineage differentiation assays with single CD34+CD38– cells showed no loss of multilineage potential of expanded cells after ex vivo culture. We also demonstrated that the increase in frequency of CD34+CD38– cells was not as a result of the downregulation of CD38 expression during the culture. Quantitative analysis showed that the number of 6 week cobblestone area forming cells (CAFCwk6), a measure of proliferating HSC, in cytokine‐stimulated CD34+ cells were increased by 20‐fold. Expanded CD34+CD38– cells could be transduced efficiently with retroviruses encoding the low affinity nerve growth factor receptor (LNGFR) marker gene (17% to 44%, mean 27%), resulting in long‐lasting expression of retroviral‐encoded genes in progeny HSC and differentiated progenitors. We conclude that the combination Flt3‐ligand (FL), stem cell factor and thrombopoietin (TPO) induced strong ex vivo proliferation of CD34+CD38– cells and that the absolute number of expanded cells with stem cell activity increased substantially in this population.This publication has 32 references indexed in Scilit:
- Human Cord Blood CD34+CD38- Cell Transduction via Lentivirus-Based Gene Transfer VectorsHuman Gene Therapy, 1999
- CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivoExperimental Hematology, 1999
- Efficient Transduction of Human Lymphocytes and CD34+ Cells via Human Immunodeficiency Virus-Based Gene Transfer VectorsHuman Gene Therapy, 1999
- Selective Immunoaffinity-Based Enrichment of CD34+Cells Transduced with Retroviral Vectors Containing an Intracytoplasmatically Truncated Version of the Human Low-Affinity Nerve Growth Factor Receptor (ΔLNGFR) GeneHuman Gene Therapy, 1997
- Cell-Surface Marking of CD34+-Restricted Phenotypes of Human Hematopoietic Progenitor Cells by Retrovirus-Mediated Gene TransferHuman Gene Therapy, 1997
- The Biology of Hematopoietic Stem CellsAnnual Review of Cell and Developmental Biology, 1995
- Development of retrovirally marked human T progenitor cells into mature thymocytesInternational Immunology, 1995
- Retrovirus‐mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cellsBritish Journal of Haematology, 1994
- Hematopoietic stem cellsCurrent Opinion in Immunology, 1992
- Regulation of Hemopoiesis by Bone Marrow Stromal Cells and Their ProductsAnnual Review of Immunology, 1990